The US insulin pump market is on a remarkable growth trajectory, projected to reach a staggering $5.37 billion by 2035, reflecting a compound annual growth rate (CAGR) of 13.45%. This impressive surge is primarily driven by technological advancements in insulin delivery systems and a significant rise in the prevalence of diabetes across the nation. As healthcare systems evolve, the demand for...